BioMarketSATM is a series of biomedical commercialization programs designed to help startups climb toward full market success. Focused on pre‑revenue medical technology companies, this initiative provides a knowledgeable and practical pathway through the complexities of commercialization—supporting innovators as they move from promising technology to real adoption in the healthcare marketplace.
The first program in the series, VACReady, is a six‑week intensive that dives deep into the hospital decision‑making process, with a special focus on the Value Analysis Committee (VAC)—the gatekeepers of hospital technology implementation. Through a mix of virtual and in‑person sessions, participants gain insider knowledge, strategic guidance, and hands‑on training to confidently present their solutions to hospital stakeholders.
Developed by BioMedSA and Cogent Consults, VACReady is cohort‑based and tailored for companies that have not yet begun commercial sales but intend to sell to hospitals after FDA approval. The program helps these startups identify the data they will need and how best to present it. At its conclusion, participants present mock data to hospital VAC representatives, gaining valuable feedback to ensure they are well‑prepared when entering the commercial market.
VACReady is only the beginning—additional BioMarketSA programs will follow, expanding the commercialization pathway for biomedical startups. To register your interest in future programs, click here.
Applications will open again soon.
Questions? Contact info@biomedsa.org.
Follow BioMedSA on social media for FAQs and updates.